Health · Moderate evidence

GLP-1: Lean Mass and Regain After Discontinuation

Trials observed substantial weight loss, with some reduction in lean mass. In the STEP 1 extension, weight regain followed withdrawal of both semaglutide and lifestyle support. Supervised exercise was studied with liraglutide.

Phase 3 randomized controlled trials, trial extension, and review · 5 sources · 2 min

What the studies show

  • Separate semaglutide and tirzepatide trials reported average losses of about 15% to over 20% over 68–72 weeks, depending on dose and protocol; these are not individual forecasts.
  • In the exploratory STEP 1 extension, one year after semaglutide and lifestyle support were withdrawn, the group regained an average of about two-thirds of the weight lost.
  • In the liraglutide trial, supervised exercise combined with medication improved maintenance and body composition; this does not automatically validate any exercise program or another medication.
  • Reviews discuss resistance training and protein as support for preserving lean mass; they do not guarantee complete preservation or provide instructions to change treatment.

How Letz applies it

For users reporting treatment, Letz prioritizes strength and protein in their targets and prepares the transition to maintenance alongside their healthcare provider.

Who it applies to

Adults with obesity on prescribed treatment.

Limits

Average results depend on the medication, dose and support. The exploratory STEP 1 extension included 327 participants and also withdrew lifestyle support; it does not isolate the effect of stopping medication. Lean mass is not only muscle. The app does not make treatment decisions.

Sources

More in Health

  • Nutritional Support During GLP-1 TreatmentMonitoring should prioritize symptoms, nutritional adequacy, protein, resistance training, and preserving lean mass and function.
  • Daily StepsMore steps per day are associated with lower mortality up to an age-dependent plateau; in weight loss programs, accumulating around 10,000 steps with a portion at a moderate pace was associated with greater weight loss.
  • Sedentary TimeAny intensity of physical activity, including light intensity, is associated with lower mortality, while more sedentary time is linked to higher risk, following a non-linear dose-response relationship.
  • Strength, Conditioning, and LongevityMuscle-strengthening activities for 30 to 60 minutes per week and higher cardiorespiratory fitness are associated with lower mortality and fewer chronic diseases.